Douglas B. Cines

ORCID: 0000-0001-5986-504X · 3 papers in corpus
guideline 2019
Blood advances ·doi:10.1182/bloodadvances.2019000966

BACKGROUND: Despite an increase in the number of therapies available to treat patients with immune thrombocytopenia (ITP), there are minimal data from randomized trials to assist physicians with the management of patients. OBJECTIVE: These…

nonrandomized-trial 2008
British journal of haematology ·doi:10.1111/j.1365-2141.1991.tb08617.x

Peripheral cytopenias are common in patients with myelodysplastic syndromes. We previously successfully treated three such patients with improvement of some cytopenias with the impeded androgen danazol. To confirm this finding and elucidate…

case-report 1985
Annals of internal medicine ·doi:10.7326/0003-4819-103-1-58

Platelet-associated IgG was markedly elevated in three patients with myelodysplasia and severe thrombocytopenia that had become refractory to platelet transfusions. The patients were treated with danazol because of its efficacy in treating …